| Date | Insider | Type | Value | |
|---|---|---|---|---|
| Mar 17, 26 | Justin Lockwood | Grant | - | |
| Mar 17, 26 | Simon Bourne | Grant | - | |
| Mar 11, 26 | Justin Lockwood | Buy | $201 | |
| Mar 11, 26 | Simon Bourne | Buy | $201 | |
| Feb 13, 26 | Marshalls EBT Limited | Grant | $3 | |
| Feb 13, 26 | Simon Bourne | Buy | $204 | |
| Feb 13, 26 | Justin Lockwood | Buy | $202 | |
| Jan 9, 26 | Justin Lockwood | Buy | $202 | |
| Jan 9, 26 | Simon Bourne | Buy | $199 | |
| Dec 9, 25 | Marshalls EBT Limited | Grant | $9.2M |
Marshalls (MSLH) has recorded 0 insider transactions from 0 insiders. Total insider buying volume stands at $0, while total selling volume is $0. Insider activity shows a balanced mix of buying and selling.
Marshalls (MSLH) has recorded 0 insider operations, including 0 open-market purchases ($0), 0 sales ($0). The insider sentiment is balanced.
Insider activity at Marshalls is sustained, with operations recorded in 12 of the last 12 months — a sign of regular regulatory filings.
Across all 187 recorded transactions, the breakdown by type is: buys (135, 72%), grant (33, 18%), subscription (10, 5%), sells (4, 2%), dividend (3, 2%).
Data sourced from regulatory filings (SEC Form 4, AMF, BaFin, FI, and other European authorities).
Marshalls has recorded 0 insider operations in total, including 0 open-market purchases ($0), 0 sales ($0).
Insiders at Marshalls show balanced activity with 50% purchases and 50% sales. Total buy volume is $0 versus $0 in sales.
InsiderLens tracks 0 insiders at Marshalls (MSLH). Data is sourced from mandatory regulatory filings for persons with access to privileged information.
The insider signal for MSLH is neutral, based on a 50% buy ratio across 0 buy and sell transactions reported to financial regulators. Transactions from C-suite executives (CEO, CFO) and board members are generally considered the most informative signals.
Insider trading data for Marshalls comes from official regulatory filings: SEC Form 4 (United States), AMF (France), BaFin (Germany), FI (Sweden), and other European financial authorities. These filings are mandatory for directors, officers, and holders of more than 10% of a company's shares. InsiderLens aggregates and normalizes this data for analysis.